T. Rowe Price Investment Management Inc. Has $28.79 Million Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• T. Rowe Price Investment Management Inc. has significantly reduced its holdings in Acadia Healthcare by 84.5%, selling over 5 million shares during the first quarter, leaving the firm with a remaining 949,569 shares valued at approximately $28.79 million.
• Multiple hedge funds have adjusted their positions in Acadia Healthcare, with notable increases from Banco Bilbao Vizcaya Argentaria (+80.6%) and Hsbc Holdings (+41.6%) in the same period.
• Acadia Healthcare recently reported earnings exceeding analysts' expectations, with an EPS of $0.83 and a revenue increase of 9.2% year-over-year, despite price target cuts from several equity analysts.

T. Rowe Price Investment Management Inc. lessened its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 84.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 949,569 shares of the company's stock after selling 5,166,423 shares during the period. T. Rowe Price Investment Management Inc. owned 1.03% of Acadia Healthcare worth $28,791,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ACHC. Citigroup Inc. raised its position in shares of Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after acquiring an additional 2,330,898 shares during the last quarter. Madison Avenue Partners LP bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at $76,339,000. Sachem Head Capital Management LP bought a new stake in shares of Acadia Healthcare in the 4th quarter valued at $52,734,000. Balyasny Asset Management L.P. bought a new stake in shares of Acadia Healthcare in the 4th quarter valued at $43,092,000. Finally, Brown Advisory Inc. bought a new stake in shares of Acadia Healthcare in the 1st quarter valued at $25,125,000.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ACHC. Raymond James Financial reaffirmed an "outperform" rating and issued a $26.00 target price (down from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Barclays reduced their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Mizuho reduced their price objective on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research note on Wednesday, August 13th. Guggenheim reduced their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Finally, KeyCorp reduced their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Nine research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $40.77.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded up $0.29 during trading hours on Friday, hitting $22.91. The company had a trading volume of 590,359 shares, compared to its average volume of 2,191,210. The firm has a market cap of $2.12 billion, a PE ratio of 15.16, a PEG ratio of 4.37 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $82.40. The firm has a 50-day moving average of $21.99 and a 200 day moving average of $25.68.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. During the same period in the previous year, the company posted $0.91 earnings per share. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.